Core Insights - Southbound funds reduced their holdings in HeartCare Medical-B (02160.HK) by 223,000 shares on October 13, 2025, marking a continuous trend of selling over the past trading days [1] - Over the last 5 trading days, there has been a total net reduction of 724,000 shares, while in the last 20 trading days, the cumulative net reduction reached 1,385,000 shares [1] - As of now, southbound funds hold 111 million shares of HeartCare Medical-B, which represents 4.59% of the company's total issued ordinary shares [1] Company Overview - HeartCare Medical Technology Co., Ltd. specializes in providing comprehensive medical solutions for treating structural heart diseases [2] - The company's main business involves the research and commercialization of transcatheter and surgical solutions in the field of structural heart disease [2] - The product pipeline includes transcatheter aortic valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) products, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products, and surgical support products [2] - The company operates in both domestic and international markets [2]
心通医疗-B（02160.HK）：10月13日南向资金减持22.3万股